Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Limited utility as an indicator of deficiency; concentration does not correlate well with intake. Zinc, Serum or Plasma concentrations (0020097) are best for assessment of deficiency over short periods of time. For acute toxicity, Zinc, Urine (0020462) may be a more reliable indicator of exposure.
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
1-3 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Diet, medication, and nutritional supplements may introduce interfering substances. Patient should be encouraged to discontinue nutritional supplements, vitamins, minerals, and non-essential over-the-counter medications (upon the advice of their physician).
Collect
Royal Blue (K2EDTA or Na2EDTA).
Specimen Preparation
Transport 2 mL whole blood in the original collection tube. (Min: 0.5 mL)
Storage/Transport Temperature
Room temperature. Also acceptable: Refrigerated.
Unacceptable Conditions
Specimens collected in tubes other than Royal Blue (EDTA). Specimens transported in containers other than a Royal Blue (EDTA) tube or Trace Element-Free Transport Tube. Heparin anticoagulant. Clotted specimens.
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
440.0-860.0 µg/dL
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Elevated results may be due to skin or collection-related contamination, including the use of a noncertified metal-free collection/transport tube. If contamination concerns exist due to elevated levels of blood zinc, confirmation with a second specimen collected in a certified metal-free tube is recommended.
Zinc concentration in blood has not been shown to change significantly in deficiency or with supplementation.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Compliance Category
Laboratory Developed Test (LDT)
NoteAdditional information related to the test.
Hotline History
N/A
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.
Chat
Feedback
